You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 301 No. 7, February 18, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •Statistics and Research Methods
 •Drug Therapy
 •Adverse Effects
 •Endocrine Diseases
 •Diabetes Mellitus
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Association of Bisphenol A With Diabetes and Other Abnormalities—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: Dr Wei and Ms Howard and Dr Howard comment on the observed association between BPA and diabetes in our study. Respondents to the NHANES 2003-2004 were asked, "Other than during pregnancy, have you ever been told by a doctor or health professional that you have diabetes or sugar diabetes?" Our analyses included 124 respondents replying yes plus 12 recorded as borderline. In fully adjusted models, geometric mean concentration of urinary BPA in the no group was 2.45 ng/mL (95% confidence interval [CI], 2.26-2.65 ng/mL); in the small borderline group, 5.97 ng/mL (95% CI, 4.01-8.88 ng/mL); and in the yes group, 2.86 ng/mL (95% CI, 2.42-3.37 ng/mL). Excluding the borderline response attenuated outcomes slightly in fully adjusted models: the odds ratio (OR) for responding yes vs no was 1.19 (95% CI, 1.00-1.41; P = .05) per 1-SD increase in BPA concentration. This equated to an OR of 2.38 (95% CI, . . . [Full Text of this Article]

David Melzer, MB, PhD
david.melzer@pms.ac.uk

Iain A. Lang, PhD
Epidemiology and Public Health Group
Peninsula Medical School
Exeter, United Kingdom

Tamara S. Galloway, PhD
School of Biosciences
University of Exeter
Exeter



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Association of Urinary Bisphenol A Concentration With Medical Disorders and Laboratory Abnormalities in Adults
Iain A. Lang, Tamara S. Galloway, Alan Scarlett, William E. Henley, Michael Depledge, Robert B. Wallace, and David Melzer
JAMA. 2008;300(11):1303-1310.
ABSTRACT | FULL TEXT  

RELATED LETTERS

Association of Bisphenol A With Diabetes and Other Abnormalities
Ming Wei
JAMA. 2009;301(7):720.
EXTRACT | FULL TEXT  

Association of Bisphenol A With Diabetes and Other Abnormalities
Sarah Howard and Timothy G. Howard
JAMA. 2009;301(7):720.
EXTRACT | FULL TEXT  

Association of Bisphenol A With Diabetes and Other Abnormalities
S. Stanley Young and Min Yu
JAMA. 2009;301(7):720-721.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.